BridgeBio Pharma, Inc. · NASDAQ:BBIO
BlackRock, Inc. reported a 5.10% stake in BridgeBio Pharma, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 27, 2026
BlackRock, Inc. reported a 5.10% stake in BridgeBio Pharma, Inc., 9,892,226 shares, as a passive investor on Sep 30, 2026. Filed Oct 27, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 9,892,226
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 9,892,226 |
Source
Download original · View original at SEC
Related
- BridgeBio Pharma, Inc.
- BlackRock, Inc.
- BridgeBio Pharma, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Kumar Neil · Nov 20, 2026
- Form 4 · Kumar Neil · Nov 18, 2026
- Form 4 · Apuli Maricel · Nov 18, 2026
- Form 4 · Trimarchi Thomas · Nov 18, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 12, 2026